Duffy M J, Brouillet J P, Reilly D, McDermott E, O'Higgins N, Fennelly J J, Maudelonde T, Rochefort H
Department of Nuclear Medicine, St. Vincent's Hospital, Dublin, Ireland.
Clin Chem. 1991 Jan;37(1):101-4.
Cathepsin D (CD, EC 3.4.23.5) is a lysosomal protease induced by estrogen in certain estrogen receptor (ER)-positive breast cancer cell lines but produced constitutively by ER-negative cell lines. Our aims in this investigation were to study the distribution of CD in human breast cancers and to relate its concentrations to various biochemical, histological, and clinical characteristics. The concentrations of CD were significantly higher in breast carcinomas than in either normal breast tissues or benign breast tumors. In primary carcinomas, CD concentrations did not correlate with the concentrations of ER or with the estrogen-inducible protease t-PA. However, CD concentrations did correlate weakly but significantly with both UK-PA antigen and UK-PA activity. Also, CD concentrations did not correlate with either tumor stage or axillary node status but did correlate significantly with tumor grade. Patients with cancers containing high concentrations of CD had a significantly shorter overall survival than did patients with low concentrations of the enzyme.
组织蛋白酶D(CD,EC 3.4.23.5)是一种溶酶体蛋白酶,在某些雌激素受体(ER)阳性乳腺癌细胞系中由雌激素诱导产生,但在ER阴性细胞系中组成性产生。我们本次研究的目的是研究CD在人类乳腺癌中的分布,并将其浓度与各种生化、组织学和临床特征联系起来。乳腺癌中CD的浓度显著高于正常乳腺组织或良性乳腺肿瘤。在原发性癌中,CD浓度与ER浓度或雌激素诱导的蛋白酶组织型纤溶酶原激活物(t-PA)均无相关性。然而,CD浓度与尿激酶型纤溶酶原激活物(UK-PA)抗原及UK-PA活性呈弱但显著的相关性。此外,CD浓度与肿瘤分期或腋窝淋巴结状态均无相关性,但与肿瘤分级显著相关。CD浓度高的癌症患者的总生存期明显短于该酶浓度低的患者。